What this study is
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
What's being tested
- Biospecimen Collection
Intervention · PROCEDURE
Undergo collection of tumor tissue, blood, saliva, and urine samples
Study details
- Official title
- University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
- Sponsor
- University of California, Davis
- Conditions
- Bladder Carcinoma · Gastric Carcinoma · Liver and Intrahepatic Bile Duct Carcinoma · Lung Carcinoma · Malignant Neoplasm
- Enrolling
- 500 people
- Starts
- 2019-11-12
- Est. completion
- 2027-06
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 21 Years – 100 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
- Signed informed consent that will be put on file
You can't join if
- No informed consent obtained
- Specimen unacceptable/degraded/etc.
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Adults unable to consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openUC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, United States
- Marian Waterman · Contact949-824-2885marian.waterman@uci.edu
- Marian Waterman · Principal investigator
RecruitingUniversity of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Luis G. Carvajal-Carmona · Contact530-752-9654lgcarvajal@ucdavis.edu
- Luis G. Carvajal-Carmona · Principal investigator
Recruiting
Study team
Sponsor
University of California, Davis
Study ID 1420270
Principal investigator
Luis G Carvajal-Carmona
University of California, Davis
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.